A cross-sectional study characterized the cannabis products purchased from a single New York State manufacturer, providing rare real-world data on medical cannabis product selection patterns.
Medical cannabis regulators, dispensary operators, clinicians, and health services researchers.
Real purchase data from a regulated NY dispensary system
What the researchers found
This study examined medical cannabis product purchases in New York State from dispensaries operated by a single integrated manufacturer, characterizing what products patients actually selected in a tightly regulated market.
Why it matters
Most medical cannabis research relies on self-report. This study uses actual purchase data from a regulated market, providing objective insight into patient product preferences.
The numbers in context
New York State dispensary purchase data from a single integrated manufacturer-retailer. Specific product details characterized.
How the study worked
Cross-sectional study of medical cannabis product purchases made in New York State dispensaries operated by a single licensed manufacturer and retail company. Published in JAMA Network Open.
What this study cannot tell us
Single manufacturer in one state. New York had one of the most restrictive medical cannabis programs at the time. May not represent patient preferences in less regulated markets.
How to read the evidence
Cross-sectional study using objective purchase data from a regulated market, published in JAMA Network Open.
When this study was published
Published in 2022.
The bigger picture
As medical cannabis markets mature, understanding actual purchasing behavior helps regulators, clinicians, and researchers align product availability with patient needs.
Questions still open
- Do patients in less restrictive states choose different products? Does product type influence treatment outcomes?
Common questions
What medical cannabis products do patients actually buy?
Does the type of medical cannabis product matter?
Read the original research
Characterization of Cannabis Products Purchased for Medical Use in New York State.
JAMA network open, 5(8), e2227735
Citation
Kritikos, Alexandra F; Pacula, Rosalie Liccardo. (2022). Characterization of Cannabis Products Purchased for Medical Use in New York State.. JAMA network open, 5(8), e2227735. https://doi.org/10.1001/jamanetworkopen.2022.27735
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk